Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Chrystyn

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 22, 2019
Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhalerMohamad Abadelah, Henry Chrystyn, Hassan Larhrib
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 28, 2023
Dry Powder Inhalers: From Bench to BedsideHenry Chrystyn, Wahida Azouz, Walid Tarsin
Respiratory Care|May 30, 2019
Bioavailability of Beclometasone From Two HFA-BDP Formulations With a SpacerAmira Sa Said, Salahdein AbuRuz, Henry Chrystyn
The Journal of Pharmacy and Pharmacology|November 13, 2008
Salbutamol relative lung and systemic bioavailability of large and small spacersSyed H R A Mazhar, Henry Chrystyn
The Journal of Pharmacy and Pharmacology|July 29, 2010
In-vitro characterisation of the nebulised dose during non-invasive ventilationMohamed E Abdelrahim, Paul Plant, Henry Chrystyn
International Journal of Pharmaceutics|March 4, 2017
Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort<sup>®</sup> Turbuhaler<sup>®</sup>Golshan Bagherisadeghi, El Hassane Larhrib, Henry Chrystyn
Pharmacy World & Science : PWS|January 7, 2003
Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepinesJulie D Morgan, David J Wright, Henry Chrystyn
International Journal of Pharmaceutics|July 30, 2013
Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volumeSani Ibn Yakubu, Khaled H Assi, Henry Chrystyn
British Journal of Clinical Pharmacology|March 15, 2011
Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretionMohamed E Abdelrahim, Khaled H Assi, Henry Chrystyn
Maturitas|September 7, 2005
Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal womenAbdulbaset Elfituri, Fathi Sherif, Mohamed Elmahaishi, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 22, 2019
Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhalerMohamad Abadelah, Henry Chrystyn, Hassan Larhrib
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 28, 2023
Dry Powder Inhalers: From Bench to BedsideHenry Chrystyn, Wahida Azouz, Walid Tarsin
Respiratory Care|May 30, 2019
Bioavailability of Beclometasone From Two HFA-BDP Formulations With a SpacerAmira Sa Said, Salahdein AbuRuz, Henry Chrystyn
The Journal of Pharmacy and Pharmacology|November 13, 2008
Salbutamol relative lung and systemic bioavailability of large and small spacersSyed H R A Mazhar, Henry Chrystyn
The Journal of Pharmacy and Pharmacology|July 29, 2010
In-vitro characterisation of the nebulised dose during non-invasive ventilationMohamed E Abdelrahim, Paul Plant, Henry Chrystyn
International Journal of Pharmaceutics|March 4, 2017
Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort<sup>®</sup> Turbuhaler<sup>®</sup>Golshan Bagherisadeghi, El Hassane Larhrib, Henry Chrystyn
Pharmacy World & Science : PWS|January 7, 2003
Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepinesJulie D Morgan, David J Wright, Henry Chrystyn
International Journal of Pharmaceutics|July 30, 2013
Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volumeSani Ibn Yakubu, Khaled H Assi, Henry Chrystyn
British Journal of Clinical Pharmacology|March 15, 2011
Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretionMohamed E Abdelrahim, Khaled H Assi, Henry Chrystyn
Maturitas|September 7, 2005
Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal womenAbdulbaset Elfituri, Fathi Sherif, Mohamed Elmahaishi, et al.
Pageof 9